3S Bio raises a healthy $711m via HK IPO

The mainland Chinese biotech firm generated strong demand, with the retail tranche of the offering on the Hong Kong bourse 200-times oversubscribed.
June 07, 2015

Biotech company 3S Bio raised $711 million in a Hong Kong initial public offering on Friday after pricing shares at the top of the range.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at subscriptions@financeasia.com. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media